Trials / Unknown
UnknownNCT03237507
Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer
Prospective and Non-interventional Study on Peritoneal Metastasis of Stage IV Gastric Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (estimated)
- Sponsor
- Harbin Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a non-interventional study，aim to observe the safety and efficiency of different treatment regimen for peritoneal metastasis of Stage IV gastric cancer in the real world
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-1 | 40-60mg/m\^2 bid, days 1-14, oral，every 3 weeks. |
| DRUG | oxaliplatin | 100mg/m\^2 days 1，intravenous infusion, every 3 weeks. |
| DEVICE | Hyperthermic Intraperitoneal | hyperthermic intraperitoneal chemoperfusion |
| DRUG | Paclitaxel | intraperitoneal perfusion |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2019-06-01
- Completion
- 2020-06-01
- First posted
- 2017-08-02
- Last updated
- 2017-08-02
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03237507. Inclusion in this directory is not an endorsement.